Safety, activity, and pharmacokinetics of GLQ223 in patients with AIDS and AIDS-related complex.
GLQ223 is a highly purified single-chain ribosome-inactivating protein with selective effects against a variety of cells, including macrophages infected with human immunodeficiency virus. We evaluated the safety, pharmacokinetics, and immunologic effects of multiple doses of GLQ223 in 22 patients wi...
שמור ב:
| הוצא לאור ב: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1994
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284438/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7910722/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.2.260 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
